SRI Antibody Blocking Peptide

• Applications: AC
• Concentration: 1 mg/ml

SRI Antibody Blocking Peptide Summary

• Specificity: This peptide is specific for NBP2-24479 only.
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: SRI

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP2-24479. For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -80C. Avoid freeze-thaw cycles.
• Buffer: Peptide dissolved in dH20. Contains no BSA.
• Preservative: No Preservative
• Concentration: 1 mg/ml

Alternate Names for SRI Antibody Blocking Peptide

• calcium binding protein amplified in mutlidrug-resistant cells
• CP22
• CP-22
• FLJ26259,22 kDa protein
• H_RG167B05.1
• SCN
• sorcin
• V19

Background

Sorcin (SRI) is a Ca2+-binding protein first identified in multidrug-resistant cells. This protein is widely distributed in mammalian tissues, including heart and skeletal muscle. At the subcellular level, sorcin localizes to T-tubule junctions of cardiac SR and co-localizes with brain ryanodine receptors in rat brain caudate-putamen nucleus.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: SRI